Search Results - "Dahodwala, Nabila"

Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis by Quinn, Colin, Edmundson, Christyn, Dahodwala, Nabila, Elman, Lauren

“…Background Validation of biomarkers of upper motor neuron (UMN) impairment in amyotrophic lateral sclerosis (ALS) requires a reliable clinical assessment of…”
Get full text

Current and projected future economic burden of Parkinson’s disease in the U.S by Yang, Wenya, Hamilton, Jamie L., Kopil, Catherine, Beck, James C., Tanner, Caroline M., Albin, Roger L., Ray Dorsey, E., Dahodwala, Nabila, Cintina, Inna, Hogan, Paul, Thompson, Ted

“…Parkinson’s disease (PD) is one of the world’s fastest growing neurological disorders. Much is unknown about PD-associated economic burdens in the United…”
Get full text

Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention by Vaswani, Pavan A., Tropea, Thomas F., Dahodwala, Nabila

“…Parkinson disease (PD) is highly prevalent among neurodegenerative diseases, affecting a diverse patient population. Despite a general willingness of patients…”
Get full text

Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 by Dorsey, E. Ray, Elbaz, Alexis, Nichols, Emma, Abbasi, Nooshin, Abd-Allah, Foad, Abdelalim, Ahmed, Adsuar, Jose C., Ansha, Mustafa Geleto, Brayne, Carol, Choi, Jee-Young J, Collado-Mateo, Daniel, Dahodwala, Nabila, Do, Huyen Phuc, Edessa, Dumessa, Endres, Matthias, Fereshtehnejad, Seyed-Mohammad, Foreman, Kyle J, Gankpe, Fortune Gbetoho, Gupta, Rahul, Hamidi, Samer, Hankey, Graeme J., Hay, Simon I., Hegazy, Mohamed I, Hibstu, Desalegn T., Kasaeian, Amir, Khader, Yousef, Khalil, Ibrahim, Khang, Young-Ho, Kim, Yun Jin, Kokubo, Yoshihiro, Logroscino, Giancarlo, Massano, João, Mohamed Ibrahim, Norlinah, Mohammed, Mohammed A., Mohammadi, Alireza, Moradi-Lakeh, Maziar, Naghavi, Mohsen, Nguyen, Binh Thanh, Nirayo, Yirga Legesse, Ogbo, Felix Akpojene, Owolabi, Mayowa Ojo, Pereira, David M., Postma, Maarten J, Qorbani, Mostafa, Rahman, Muhammad Aziz, Roba, Kedir T., Safari, Hosein, Safiri, Saeid, Satpathy, Maheswar, Sawhney, Monika, Shafieesabet, Azadeh, Shiferaw, Mekonnen Sisay, Smith, Mari, Szoeke, Cassandra E I, Tabarés-Seisdedos, Rafael, Truong, Nu Thi, Ukwaja, Kingsley Nnanna, Venketasubramanian, Narayanaswamy, Villafaina, Santos, weldegwergs, Kidu gidey, Westerman, Ronny, Wijeratne, Tissa, Winkler, Andrea S., Xuan, Bach Tran, Yonemoto, Naohiro, Feigin, Valery L, Vos, Theo, Murray, Christopher J L

“…Neurological disorders are now the leading source of disability globally, and ageing is increasing the burden of neurodegenerative disorders, including…”
Get full text

Analysis of the treatment of neuromyelitis optica by Torres, Jose, Pruitt, Amy, Balcer, Laura, Galetta, Steven, Markowitz, Clyde, Dahodwala, Nabila

“…Abstract Background Treatment options for neuromyelitis optica (NMO) are currently based on small retrospective case series and open label studies, ranging…”
Get full text

Longitudinal study of normal cognition in Parkinson disease by Pigott, Kara, Rick, Jacqueline, Xie, Sharon X, Hurtig, Howard, Chen-Plotkin, Alice, Duda, John E, Morley, James F, Chahine, Lama M, Dahodwala, Nabila, Akhtar, Rizwan S, Siderowf, Andrew, Trojanowski, John Q, Weintraub, Daniel

“…OBJECTIVE:To report the rates and predictors of progression from normal cognition to either mild cognitive impairment (MCI) or dementia using standardized…”
Get full text

Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease by Roalf, David R, Moore, Tyler M, Wolk, David A, Arnold, Steven E, Mechanic-Hamilton, Dawn, Rick, Jacqueline, Kabadi, Sushila, Ruparel, Kosha, Chen-Plotkin, Alice S, Chahine, Lama M, Dahodwala, Nabila A, Duda, John E, Weintraub, Daniel A, Moberg, Paul J

“…IntroductionScreening for cognitive deficits is essential in neurodegenerative disease. Screening tests, such as the Montreal Cognitive Assessment (MoCA), are…”
Get full text

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data by Pagano, Gennaro, Boess, Frank G, Taylor, Kirsten I, Ricci, Benedicte, Mollenhauer, Brit, Poewe, Werner, Boulay, Anne, Anzures-Cabrera, Judith, Vogt, Annamarie, Marchesi, Maddalena, Post, Anke, Nikolcheva, Tania, Kinney, Gene G, Zago, Wagner M, Ness, Daniel K, Svoboda, Hanno, Britschgi, Markus, Ostrowitzki, Susanne, Simuni, Tanya, Marek, Kenneth, Koller, Martin, Sevigny, Jeff, Doody, Rachelle, Fontoura, Paulo, Umbricht, Daniel, Bonni, Azad

“…Currently available treatments for Parkinson's disease (PD) do not slow clinical progression nor target alpha-synuclein, a key protein associated with the…”
Get full text

Unique characteristics of end-of-life hospitalizations in Parkinson disease by Aamodt, Whitley W, Dahodwala, Nabila, Bilker, Warren B, Farrar, John T, Willis, Allison W

“…Persons with Parkinson disease (PD) are hospitalized at higher rates, have longer lengths of stay, and are more likely to die in the hospital than age-matched…”
Get full text

APOE, thought disorder, and SPARE‐AD predict cognitive decline in established Parkinson's disease by Tropea, Thomas F., Xie, Sharon X., Rick, Jacqueline, Chahine, Lana M., Dahodwala, Nabila, Doshi, Jimit, Davatzikos, Christos, Shaw, Leslie M., Van Deerlin, Vivianna, Trojanowski, John Q., Weintraub, Daniel, Chen‐Plotkin, Alice S.

“…ABSTRACT Background People with PD are at high risk of developing cognitive impairment and dementia. Cross‐sectional studies have identified candidate…”
Get full text

Cognitive impairment in Parkinson’s disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health by Goldman, Jennifer G., Vernaleo, Beth A., Camicioli, Richard, Dahodwala, Nabila, Dobkin, Roseanne D., Ellis, Terry, Galvin, James E., Marras, Connie, Edwards, Jerri, Fields, Julie, Golden, Robyn, Karlawish, Jason, Levin, Bonnie, Shulman, Lisa, Smith, Glenn, Tangney, Christine, Thomas, Cathi A., Tröster, Alexander I., Uc, Ergun Y., Coyan, Noreen, Ellman, Crystal, Ellman, Mike, Hoffman, Charlie, Hoffman, Susan, Simmonds, Don

“…People with Parkinson’s disease (PD) and their care partners frequently report cognitive decline as one of their greatest concerns. Mild cognitive impairment…”
Get full text

Associations and Implications of Low Health Literacy in Parkinson's Disease by Fleisher, Jori E., Shah, Krunal, Fitts, Whitney, Dahodwala, Nabila A.

“…Background Low health literacy (HL) indicates a limited ability to understand and use basic information to make appropriate health care decisions. Whereas low…”
Get full text

Genetic and phenotypic characterization of Parkinson’s disease at the clinic-wide level by Tropea, Thomas F., Hartstone, Whitney, Amari, Noor, Baum, Dylan, Rick, Jacqueline, Suh, Eunran, Zhang, Hanwen, Paul, Rachel A., Han, Noah, Zack, Rebecca, Brody, Eliza M., Albuja, Isabela, James, Justin, Spindler, Meredith, Deik, Andres, Aamodt, Whitley W., Dahodwala, Nabila, Hamedani, Ali, Lasker, Aaron, Hurtig, Howard, Stern, Matthew, Weintraub, Daniel, Vaswani, Pavan, Willis, Allison W., Siderowf, Andrew, Xie, Sharon X., Van Deerlin, Vivianna, Chen-Plotkin, Alice S.

“…Observational studies in Parkinson’s disease (PD) deeply characterize relatively small numbers of participants. The Molecular Integration in Neurological…”
Get full text

Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity by Dahodwala, Nabila, Pettit, Amy R., Jahnke, Jordan, Li, Pengxiang, Ladage, Vrushabh P., Kandukuri, Prasanna L., Zamudio, Jorge, Jalundhwala, Yash J., Doshi, Jalpa A.

“…Lack of a gold standard definition for advanced Parkinson's Disease (APD), coupled with absence of disease severity information in diagnostic codes, hinders…”
Get full text

Facial tic associated with lamotrigine in adults by Musiek, Erik S., Anderson, Christopher T., Dahodwala, Nabila A., Pollard, John R.

Get full text

Validation of an instrument to measure older adults' expectations regarding movement (ERM) by Dahodwala, Nabila, Karlawish, Jason, Shea, Judy A, Zubritsky, Cynthia, Stern, Matthew, Mandell, David S

“…Many individuals with Parkinson's disease are not diagnosed and treated. Attitudes about aging and related help-seeking may affect the timely diagnosis of…”
Get full text

Impact of caregiver characteristics on patient outcomes in Parkinson’s disease (P2-11.006) by Rashid, Rudmila, Dahodwala, Nabila

“…Abstract only…”
Get full text

Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx) by Fleisher, Jori E, Dahodwala, Nabila A, Xie, Sharon X, Mayo, Mark, Weintraub, Daniel, Chodosh, Joshua, Shea, Judy A

“…Medication non-adherence is common in Parkinson's disease (PD) and is associated with increased disability and healthcare costs. Individuals' beliefs regarding…”
Get more information

Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson’s disease and dementia with Lewy bodies (P2.8-037) by Horn, Sarah, Dahodwala, Nabila

“…Abstract only…”
Get full text

Sex differences in Parkinson's disease and other movement disorders by Smith, Kara M., Dahodwala, Nabila

“…Movement disorders including Parkinson's disease (PD), Huntington's disease (HD), chorea, tics, and Tourette's syndrome (TS) display sex differences in disease…”
Get full text